BAUSCH HEALTH COMPANIES INC F/K/A VALEANT PHARMACEUTICALS INTERNATIONAL INC

Lobbying Spend

—

Filings

Firms Hired

Active Period

2017–2020

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2020	—	1	1
2019	—	4	1
2018	—	5	1
2017	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
KING & SPALDING LLP	—	12

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Food & Drug Administration (FDA)	3
HOUSE OF REPRESENTATIVES	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	12

BAUSCH HEALTH COMPANIES INC F/K/A VALEANT PHARMACEUTICALS INTERNATIONAL INC — Lobbying Disclosure | Poliscope